fluorescent ca 2 indicator fluo 3 am (MedChemExpress)
Structured Review

Fluorescent Ca 2 Indicator Fluo 3 Am, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 19 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/fluorescent ca 2 indicator fluo 3 am/product/MedChemExpress
Average 94 stars, based on 19 article reviews
Images
1) Product Images from "Adaptable thermoresponsive polymer for long-term electrical coupling in plant electrophysiology monitoring"
Article Title: Adaptable thermoresponsive polymer for long-term electrical coupling in plant electrophysiology monitoring
Journal: Science Advances
doi: 10.1126/sciadv.ady1400
Figure Legend Snippet: ( A ) Procedure of drought stress and recovery experiment and photographs of plants under testing. Predrought is defined as 1 day before plants display wilting symptoms. ( B ) Amplitude of light-induced potential change for plants under 9 days of escalating drought (red) benchmarked against well-watered control plants (gray), showing an increase followed by decrease upon wilting. a.u., arbitrary units. ( C ) Light-induced potential change before and after inhibition of Ca 2+ channels in the same leaf. N = 3. ( D ) Light-induced potential change before and after inhibition of ROS production in the same leaf. N = 3. ( E ) Confocal images of intracellular Ca 2+ (top) and apoplastic ROS (bottom) during drought simulation, with quantification of the mean fluorescence intensity per region of interest (ROI) shown on the right. BF, bright field. Fluo-3 AM and 2′,7′-dichlorodihydrofluorescein diacetate (H 2 DCFDA): dyes used for visualizing Ca 2+ and ROS, respectively. Scale bar, 50 μm. CK, control plants; DR, drought-stressed plants. ( F ) Plant EP signals under the light and dark conditions with starting potential aligned for all samples on each day. N = 6. ( G ) Mean potential calculated from signals in (F) 1 hour after light on or light off, showing opposing trends with time under light and dark conditions. Dark mean potential changes before visual symptom onset on day 7. Solid lines in (C), (D), and (F) are mean values, and shadows represent SD. Box plots in (B), (E), and (G) display first quartile, median, and third quartile. Whiskers are drawn at 1.5 interquartile range distance. Means are denoted by empty squares. * P < 0.05; *** P < 0.001; **** P < 0.0001; n.s., not significant. Two sample t test.
Techniques Used: Control, Inhibition, Fluorescence


![PD restores mitochondrial functions in OGD/R-injured neurons. (a) [Ca 2+ ] i levels in cells exposed to normoxia or hypoxia-reperfusion in the indicated groups. (b) Normalized relative fluorescence units (NRFU) of calcein indicating mPTP opening in the differentially treated cells. (c) The ratios of polymeric (red) and monomeric (green) forms of JC-1 corresponding to the MMP in the indicated groups. Scale bars = 100 μ m. (d) MitoSOX fluorescence intensity indicative of ROS levels. Data are presented as fold change over the Control group. Scale bars = 10 μ m. (e) Neuronal ATP release (nmol/mg protein) as measured by a luciferase-based assay. ∗ P < 0.05 vs. Control; # P < 0.05 vs. OGD; ΔP < 0.05 vs. OGD + PD (15 μ M).](https://pub-med-central-images-cdn.bioz.com/pub_med_central_ids_ending_with_1604/pmc08081604/pmc08081604__OMCL2021-6687212.004.jpg)
![Suppression of gp130/STAT3 reduces the inhibitory effect of SPRC on Dox-induced [Ca 2+ ] i overload. Cardiomyocytes were pretreated with/without SC144 before SPRC incubation, followed by Dox (1 μ M) stimulation for 24 h. The intracellular [Ca 2+ ] i concentration was ( a ) quantified by flow cytometry and ( b ) visualized by fluorescence microscopy using fluo-3/AM probe, a fluorescent Ca 2+ -indicator dye. Scale bars, 50 μ m. ( c ) Representative western blot analysis of SERCA2. Values are presented as mean±S.D. from n =3 replicates. # P <0.05, ### P <0.001 compared with the control group; * P <0.05, *** P <0.001 compared with the Dox group. NS, nonsignificant ( P >0.05)](https://pub-med-central-images-cdn.bioz.com/pub_med_central_ids_ending_with_8313/pmc05108313/pmc05108313__cddis2016209f6.jpg)